-
Pfizer COVID-19 vaccine works against Brazil variant in lab study
expresspharma
March 09, 2021
The scientists said the neutralising ability was roughly equivalent to the vaccine’s effect on a previous less contagious version of the virus from last year.
-
EMA and Health Canada to make COVID-19 vaccine data open access
europeanpharmaceuticalreview
March 08, 2021
Starting with the publication of clinical data used to support the authorisations of the Moderna COVID-19 vaccine, EMA and Health Canada said they will continue the open access approach for all COVID-19 vaccines.
-
AstraZeneca Advances Mass Global Rollout of COVID-19 Vaccine through COVAX
americanpharmaceuticalreview
March 08, 2021
The first of AstraZeneca’s COVID-19 vaccine have begun arriving in low and middle-income countries across the world through the multilateral COVAX initiative, the first steps in fulfilling the Company’s efforts to provide broad and equitable access to ...
-
Italy blocks export of 250,700 AstraZeneca/Oxford Covid-19 vaccines to Australia
pharmaceutical-technology
March 08, 2021
The Italian Government has refused to authorise the export of 250,700 doses of AstraZeneca/University of Oxford’s Covid-19 vaccine to Australia.
-
Oxford study indicates AstraZeneca’s COVID-19 vaccine woks against Brazil variant: Report
expresspharma
March 08, 2021
Preliminary data from a study conducted at the University of Oxford indicates that the COVID-19 vaccine developed by AstraZeneca is effective against the P1, or Brazilian variant, a source with knowledge of the study told Reuters.
-
Moderna signs supply deal with Philippines for 13 mn doses of COVID-19 vaccine
expresspharma
March 08, 2021
Moderna announced a supply agreement with the Government of The Philippines for 13 million doses of the COVID-19 Vaccine Moderna.
-
Modified COVID-19 vaccines can avoid ‘lengthy’ clinical studies, says MHRA
pharmatimes
March 05, 2021
Updated COVID-19 vaccines that are modified in response to new variants will not require a brand new approval or ‘lengthy’ clinical studies to receive authorisation, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has announced.
-
Moderna and IBM Plan to Collaborate on COVID-19 Vaccine Supply Chain and Distribution Data Sharing
prnewswire
March 05, 2021
Moderna and IBM announced their intentions to explore technologies, including artificial intelligence, blockchain and hybrid cloud, that could help support smarter COVID-19 vaccine management.
-
Bharat Biotech’s Covid-19 vaccine shows interim efficacy of 81%
pharmaceutical-technology
March 05, 2021
Indian firm Bharat Biotech has reported that the first interim analysis of Phase III study of its whole virion inactivated Covid-19 vaccine candidate, COVAXIN (BBV152), demonstrated clinical efficacy of 81%.
-
Will fast-track vaccines for coronavirus variants: UK MHRA
expresspharma
March 05, 2021
The accelerated process is based on that used for seasonal flu vaccines each year, said MHRA.